
    
      This Open Pilot Study will assess whether Duloxetine is effective for patients with Atypical
      Features. 20 patients having Major Depressive Disorder with Atypical Features or Dysthymic
      Disorder will receive Duloxetine in open fashion for 8 weeks. Dose will begin with 20 mg/d
      and increase to PDR maximal dose of 120 mg/d, if tolerated.
    
  